Startup Valuations, Biotech’s Crunch & AI’s Massive TAM | E2147

In this episode of "This Week in Startups," Alex hosts a panel discussion with investors Astasia Myers (Felicis), Matt Turck (FirstMark), and D.A. Wallach (Time BioVentures) to analyze Q2 dealmaking and investment strategies across different sectors. The conversation covers the dynamics of AI investments, with Myers and Turck noting high valuations and intense competition but also significant market opportunities and rapid growth. Wallach provides a contrasting view from the biotech sector, describing a challenging fundraising environment and a market downturn. The discussion extends to the impact of AI on labor markets, the potential for AI in healthcare, the rise of solo founders, and the importance of community development for early-stage startups. The investors also share insights on their portfolio companies' performance, exit strategies, and the balance between growth and profitability in the current market.